Transcatheter Aortic Valve Implantation in the Elderly: Who to Refer?
نویسندگان
چکیده
منابع مشابه
Transcatheter Aortic Valve Implantation
A 97-year-old man was referred for assessment to our transcather aortic valve implantation (TAVI) team. He had suffered multiple hospitalizations for heart failure with a signifi cantly elevated BNP at 1830 pg/mL. At the time of assessment, he had grade IV New York Heart Association (NYHA) symptoms. Until recently, he had been working actively, but this had subsequently been severely limited by...
متن کاملTranscatheter Aortic Valve Implantation
Calcific aortic stenosis (AS) is the most common form of degenerative heart valve disease in developed countries. AS predominantly affects the elderly with a prevalence of 4% in people over the age of 80 years. With increasing longevity and an ageing population the absolute number of people afflicted with AS is set to rise. The clinical course of the disease is insidious at first (Ross & Braunw...
متن کاملTranscatheter aortic valve implantation
Transcatheter aortic valve implantation was developed to offer a therapeutic solution to patients with severe symptomatic aortic stenosis who are not candidates for conventional aortic valve replacement. The improvement in transcatheter aortic valve implantation outcomes is still of concern in the areas of stroke, vascular injury, heart block, paravalvular regurgitation and valve durability. Co...
متن کاملTranscatheter aortic valve implantation
Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK *Email: [email protected] BACKGROUND AND INTRODUCTION Aortic valve (AV) disease is a common condition with its prevalence, particularly aortic stenosis increasing exponentially with advancing age. A decade ago conventional aortic valve replacement (AVR) was the only treatment when medical management failed and symp...
متن کاملTranscatheter Aortic Valve Implantation
During the past decades, the only effective treatment option for severe, symptomatic, aortic valve stenosis was surgical aortic valve replacement. More than 10 years ago, Alain Cribier performed the first transcatheter aortic valve implantation (TAVI). Since 2007, CE-mark certified aortic valves are available for TAVI. This new technology rapidly achieved a very high clinical acceptance as a tr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Progress in Cardiovascular Diseases
سال: 2014
ISSN: 0033-0620
DOI: 10.1016/j.pcad.2014.08.003